Recommendation ID
TA222/1
Question
NICE proposes that a trial should be undertaken to compare the efficacy of trabectedin plus pegylated liposomal doxorubicin hydrochloride (PLDH) with platinum-based chemotherapy because this is the standard treatment in the platinum-sensitive population.
Any explanatory notes
(if applicable)
None.

Source guidance details

Comes from guidance
Trabectedin for the treatment of relapsed ovarian cancer
Number
TA222
Date issued
April 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No